Skip to main content

Table 5 Consistency characteristics of guidelines

From: Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal

Guidelines

N

Mean (SD)

C1*

C2*

C3*

NICE

74

6.93 (0.34)

6.96 (0.26)

6.96 (0.26)

NZGG

38

6.55 (0.76)

6.39 (0.82)

6.53 (0.65)

SIGN

18

5.78 (1.11)

6.00 (0.91)

4.67 (0.59)

ADA

17

1.00 (0.00)

2.65 (1.17)

3.18 (1.24)

FIGO

40

1.20 (0.72)

1.83 (1.65)

3.45 (2.33)

Endocrine Society

25

5.04 (1.72)

6.68 (1.25)

5.88 (1.81)

CDA

17

3.53 (2.43)

4.18 (2.40)

3.88 (1.69)

API

22

5.45 (2.22)

5.45 (2.22)

5.04 (2.38)

IDF

13

1.00 (0.00)

3.38 (2.29)

2.77 (1.24)

Queensland

8

1.75 (0.71)

3.88 (1.36)

3.13 (1.25)

HKCOG

13

1.00 (0.00)

1.23 (0.60)

1.15 (0.55)

A.N.D.

15

6.00 (0.00)

5.67 (0.49)

5.93 (0.26)

DDG

21

1.05 (0.22)

1.43 (0.75)

2.24 (1.30)

CMA

40

1.00 (0.00)

1.30 (0.72)

1.15 (0.48)

Total

361

4.00 (2.74)

4.43 (2.59)

4.49 (2.42)

  1. C1*: consistency between search strategy and selection of evidence
  2. C2*: consistency between selected evidence and interpretation
  3. C3*: consistency between interpretation and resulting recommendations